kw.\*:("Blocker")
Results 1 to 25 of 2271
Selection :
Chiral chromatographic separation of β-blockersAGRAWAL, Y. K; PATEL, R. N.Journal of chromatography. B. 2005, Vol 820, Num 1, pp 23-31, issn 1570-0232, 9 p.Article
Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced whealDHANYA, N. B; RAI, Reena; SRINIVAS, C. R et al.Indian journal of dermatology venereology and leprology. 2008, Vol 74, Num 5, pp 475-477, issn 0378-6323, 3 p.Article
Fluvial biofilms: A pertinent tool to assess β-blockers toxicityBONNINEAU, Chloé; GUASCH, Helena; PROIA, Lorenzo et al.Aquatic toxicology. 2010, Vol 96, Num 3, pp 225-233, issn 0166-445X, 9 p.Article
Studies on the synthesis and biological activitiy of 6-ethyl-4-aryl-5-methoxycar bonyl -3,4 -dihydropyrimidin -2(1H) -onesSARAC, Selma; CIFTCI, Murat; ZORKUN, Inci Selin et al.Arzneimittel-Forschung. 2007, Vol 57, Num 3, pp 137-142, issn 0004-4172, 6 p.Article
Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failureKASAMA, Shu; TOYAMA, Takuji; KUMAKURA, Hisao et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 6, pp 884-890, issn 0161-5505, 7 p.Article
On exact blockers and anti-blockers, Δ-conjecture, and related problemsGURVICH, Vladimir.Discrete applied mathematics. 2011, Vol 159, Num 5, pp 311-321, issn 0166-218X, 11 p.Article
Crucial role of kidney function in resistance to antihypertensive therapy in patients with diabetes mellitusKOJIMA, Masayoshi; DOHI, Yasuaki; OHASHI, Masuo et al.Journal of hypertension. 2010, Vol 28, Num 11, pp 2323-2328, issn 0263-6352, 6 p.Article
Partial structures of ketoconazole as modulators of the large conductance calcium-activated potassium channel (BKCa)POWER, Eoin C; GANELLIN, C. Robin; BENTON, David C. H et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 4, pp 887-890, issn 0960-894X, 4 p.Article
Combination ace inhibitors and angiotensin II receptor blockers for hypertensionFINNEGAN, Patrick M; GLEASON, Brenda L.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 886-889, issn 1060-0280, 4 p.Article
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathyGROSS, M.-L; EL-SHAKMAK, A; SZABO, A et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 856-868, issn 0012-186X, 13 p.Article
Simultaneous blockade of α1- and β-actions of epinephrine during cardiopulmonary resuscitationLEI HUANG; SHIJE SUN; XIANGSHAO FANG et al.Critical care medicine. 2006, Vol 34, Num 12, issn 0090-3493, S483-S485, SUPConference Paper
Blockers and transversalsZENKLUSEN, R; RIES, B; PICOULEAU, C et al.Discrete mathematics. 2009, Vol 309, Num 13, pp 4306-4314, issn 0012-365X, 9 p.Article
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic painDRIZIN, Irene; GREGG, Robert J; CHAPMAN, Mark L et al.Bioorganic & medicinal chemistry. 2008, Vol 16, Num 12, pp 6379-6386, issn 0968-0896, 8 p.Article
Blocker sets, orthogonal arrays and their application to combination locksBAARTMANS, Alphonse; SANE, Sharad.Discrete mathematics. 2008, Vol 308, Num 13, pp 2885-2895, issn 0012-365X, 11 p.Article
Preclinical profile of PF9404C, a nitric oxide donor with β receptor blocking propertiesVILLARROYA, Mercedes; LOPEZ, Manuela G; DE PASCUAL, Ricardo et al.Cardiovascular drug reviews (Print). 2005, Vol 23, Num 2, pp 149-160, issn 0897-5957, 12 p.Article
Antiproliferative effect of Ca2+ channel blockers on human epidermoid carcinoma A431 cellsYOSHIDA, Junko; ISHIBASHI, Takaharu; NISHIO, Matomo et al.European journal of pharmacology. 2003, Vol 472, Num 1-2, pp 23-31, issn 0014-2999, 9 p.Article
Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mg-deficient ratTONG MAK, I; KRAMER, Jay H; WEGLICKI, William B et al.Magnesium research. 2003, Vol 16, Num 2, pp 91-97, issn 0953-1424, 7 p.Article
Beta-Blocker Supplementation of Standard Drug Treatment for SchizophreniaSHEK, Elena; BARDHAN, Sabyasachi; CHEINE, Maxim V et al.Schizophrenia bulletin. 2010, Vol 36, Num 6, pp 1079-1080, issn 0586-7614, 2 p.Article
Treatment with Irbesartan counteracts the functional remodeling of ventricular myocytes from hypertensive ratsCERBAI, Elisabetta; DE PAOLI, Petra; SARTIANI, Laura et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 5, pp 804-812, issn 0160-2446, 9 p.Article
The role of alpha-adrenoreceptors in the treatment of urological diseasesROMICS, Imre.Neurochemistry international. 2007, Vol 51, Num 5, pp 328-331, issn 0197-0186, 4 p.Conference Paper
Nantenine blocks muscle contraction and Ca2+ transient induced by noradrenaline and K+ in rat vas deferensDE A. RIBEIRO, Rosana; GARCEZ DO CARMO, Lucia; VLADIMIROVA, Irina et al.European journal of pharmacology. 2003, Vol 470, Num 1-2, pp 37-43, issn 0014-2999, 7 p.Article
Phenethyl nicotinamides, a novel class of NaV1.7 channel blockers: Structure and activity relationshipKERS, Inger; MACSARI, Istvan; LUND, Per-Eric et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 19, pp 6108-6115, issn 0960-894X, 8 p.Article
Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockersKERS, Inger; CSJERNYIK, Gabor; VENYIKE, Elisabet et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 17, pp 5618-5624, issn 0960-894X, 7 p.Article
Doxazosin as combination therapy for patients with stage 1 and stage 2 hypertensionBLACK, Henru R.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 6, pp 866-869, issn 0160-2446, 4 p.Article
Effect of β-adrenoceptor antagonist and angiotensin-converting enzyme inhibitor on hypertension-associated changes in Adenylyl cyclase type V messenger RNA expression in spontaneously hypertensive ratsFUJINO, Takayuki; HASEBE, Naoyuki; KAWABE, Jun-Ichi et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 5, pp 720-725, issn 0160-2446, 6 p.Article